ATM
MOLECULAR TARGETATM serine/threonine kinase
ATM (ATM serine/threonine kinase) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ATM
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | dactolisib | 4.25 | 69 |
| 2 | ku 55933 | 2.94 | 18 |
| 3 | pd 173074 | 2.83 | 16 |
| 4 | berzosertib | 2.30 | 9 |
| 5 | azd 7648 | 2.30 | 9 |
| 6 | azd 1390 | 2.30 | 9 |
| 7 | elimusertib | 2.08 | 7 |
| 8 | Methylene Blue | 1.61 | 4 |
| 9 | streptonigrin | 1.10 | 2 |
About ATM as a Drug Target
ATM (ATM serine/threonine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented ATM interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ATM inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.